SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001437749-21-012089
Filing Date
2021-05-13
Accepted
2021-05-13 16:31:56
Documents
8

Document Format Files

Seq Description Document Type Size
1 FORM S-1 navb20210512_s1.htm S-1 330283
2 EXHIBIT 5.1 ex_249450.htm EX-5.1 12267
3 EXHIBIT 23.1 ex_249235.htm EX-23.1 2684
4 navb20210512_s1img001.jpg GRAPHIC 2924
5 th01.jpg GRAPHIC 10003
6 th02.jpg GRAPHIC 10474
7 th03.jpg GRAPHIC 5804
8 th04.jpg GRAPHIC 3084
  Complete submission text file 0001437749-21-012089.txt   391364
Mailing Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017
Business Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-256093 | Film No.: 21920142
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences